Short-term KST
Previous Close | 19.46 |
Open | 19.61 |
Bid | 19.03 x 900 |
Ask | 19.41 x 800 |
Day's Range | 19.10 - 20.92 |
52 Week Range | 10.28 - 32.97 |
Volume | |
Avg. Volume | 1,484,555 |
Market Cap | 1.366B |
Beta (5Y Monthly) | 1.49 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.28 |
Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4,737.08 |
Artificial Intelligence (AI) is all the rage these days, promising to revolutionize industries and transform how businesses operate. Upstart Holdings (NASDAQ: UPST) and Lemonade (NYSE: LMND) are all building and improving their AI algorithms to gain a competitive advantage. Upstart Holdings is on a mission to fix the consumer lending business, which it says shuts out countless individuals because of inadequate risk models.
Historically speaking, the six-month period between May and October each year tends to deliver weaker stock market returns than the period from November to April. According to the Corporate Finance Institute, the benchmark S&P 500 index has gained an average of just 2% each year in the May-to-October period dating back to 1945. The economic challenges that plagued the stock market in 2022 seem to be resolving, with inflation continuing to return to normal levels and interest rates expected to level off later this summer and maybe even fall a bit before the end of the year.
Shares of Lemonade (NYSE: LMND) stock gained 14% in May, according to data from S&P Global Market Intelligence. Investors greeted its first-quarter earnings report, released at the start of the month, with incredible enthusiasm. Lemonade got off to a great start when it launched on the stock market in 2020.
American International's (AIG) subsidiary Corebridge will also give its regular quarterly dividend of 23 cents per share.
The Nasdaq, propelled partially by optimism about artificial intelligence (AI), is already in a bull market, as the index had soared 25% so far this year. The S&P 500, which is on the verge of a bull market as well, has also benefitted from investor enthusiasm related to the technology. So, today, we’re going to look at the best stocks for an AI-powered market. Rather than chase stocks with sky-high valuations, such as Nvidia (NASDAQ:NVDA) and C3.ai (NYSE:AI), the best AI stocks to buy for a bul
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
The mean of analysts' price targets for Lemonade (LMND) points to a 32% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Both stocks struggled as they seek to transform established industries with artificial intelligence initiatives.
Insurtech startups made lofty promises on disrupting incumbents. But they couldn’t leverage data as freely as they’d hoped—and struggled against ‘900-pound gorillas’ in the industry.
If so, you probably remember companies like GameStop and AMC Entertainment multiplying in value several times in a short period of time, only to come crashing back down when the frenzy cooled off. Here are two in particular that could be worth a look for patient investors. Lemonade (NYSE: LMND) went public in mid-2020 at a price of $29 per share and reached a high of more than $168 in January 2021 during the meme stock frenzy.
Both Lemonade (NYSE: LMND) and Upstart (NASDAQ: UPST) made their stock market debuts in 2020. Lemonade is down about 77% since going public, while Upstart's stock is down a whopping 94% from its all-time high. Lemonade is trying to change the game of insurance by using artificial intelligence (AI) to better serve customers.
Key Insights Lemonade's significant retail investors ownership suggests that the key decisions are influenced by...
At Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) recent annual meeting, insurance head Ajit Jain said that GEICO is behind on technology and is investing heavily to catch up. This might spell trouble for insurance disruptors like Lemonade (NYSE: LMND), but in this video I discuss why tech might not even be the biggest opportunity Lemonade has.
Apple and Microsoft (NASDAQ: MSFT) -- currently offer their investors a combined $5 trillion in value, but these two companies founded in the mid-1970s took over 40 years to reach this point. The technology on many investors' minds right now is artificial intelligence (AI), and there's reason to believe it will create trillions of dollars in value once this developing technology reaches maturity. Here are five companies developing AI-related products or services that could rise to the top over the next few decades to become among the largest in the world by 2050.
The insurance disruptor is still a long way from profitability, but things are moving in the right direction.
Lemonade (NYSE: LMND) wowed investors earlier this month with a better-than-expected first-quarter earnings report that demonstrated solid growth along with progress toward profitability. Just days later, at the Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) annual meeting, Ajit Jain, Warren Buffett's hand-picked manager of Berkshire Hathaway's insurance subsidiaries, made some comments that shed some light on why Lemonade may become unstoppable.
For the past two years, there was little evidence that Lemonade (NYSE: LMND) Chief Executive Officer Daniel Schreiber was correct in his belief that artificial intelligence (AI) would revolutionize the insurance industry. As a result, investors lost faith in Schreiber and his company, and the stock is down 92% from its Jan. 11, 2021, all-time high of $183.26. First-quarter results revealed a positive trend in one crucial metric investors use to evaluate if Lemonade's AI-based insurance revolution can replace conventional insurance business models.
Insurance technology company Lemonade (NYSE: LMND) has been a highly debated stock on Wall Street over the past few years. It's bringing a new business model to the insurance industry, and investors have grappled with how to value the stock. Here is why investors should consider buying shares of Lemonade for the long term.
Shares of Lemonade (NYSE: LMND) were climbing for the second session in a row on Monday as better-than-expected results in its first-quarter earnings report helped fuel an apparent short squeeze, following last week's gains. The stock closed up 11.1% on Monday after jumping 27% last Thursday and gaining another 3% on Friday. Lemonade delivered better-than-expected results in its first-quarter report, showing strong growth in customer count and in-force premium.
The consensus price target hints at a 51.2% upside potential for Lemonade (LMND). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how ING Groep (ING) and Lemonade (LMND) have performed compared to their sector so far this year.
After hitting a high of $164 per share in 2021, Lemonade (NYSE: LMND) stock has been sinking and sinking, falling to less than $11 last week. Investors lost patience with Lemonade over the past few months as losses mounted, and it was unclear whether its business was viable. Now that the company is done with its product rollouts, at least for the time being, it's working on tightening expenses and improving its loss ratio.
In 2016, Lemonade (NYSE: LMND) embarked on a journey to transform the insurance industry. It seemed crazy at the time, especially in an insurance industry that was entrenched in its traditional processes. The company just reported its 2023 first-quarter earnings and its stock soared 27% on the day.
Amid the rise of ChatGPT, the public has taken a greater interest in artificial intelligence (AI). Considering the technology's potential to increase productivity, investors have a chance to earn outsized gains in the sector's leading stocks. Knowing this potential for failure, investors might want to approach the following three stocks more cautiously.
Despite the massive rally over the last week, the insurance innovator's stock is still down roughly 92% from its high.